This is a StreetInsider.com Premium Only Page

Beam Therapeutics Inc. (BEAM) – StreetInsider.com Reports

Apr 23, 2024 02:52 PM BMO Capital Reiterates Outperform Rating on Beam Therapeutics Inc (BEAM)

Mar 26, 2024 06:31 AM Beam Therapeutics Inc. (BEAM) Announces Clearance of Clinical Trial Authorisation Application for BEAM-302

Feb 28, 2024 06:13 AM Beam Therapeutics Inc. (BEAM) Files Mixed Shelf

Feb 28, 2024 03:21 AM Beam Therapeutics Inc (BEAM) PT Raised to $42 at Barclays

Feb 27, 2024 03:17 PM Beam Therapeutics Inc (BEAM) PT Raised to $35 at RBC Capital

Feb 27, 2024 01:28 PM Beam Therapeutics Inc (BEAM) PT Raised to $57 at Wedbush

Feb 27, 2024 12:03 PM Beam Therapeutics Inc (BEAM) PT Raised to $44 at JPMorgan

Jan 29, 2024 04:28 AM JPMorgan Upgrades Beam Therapeutics Inc (BEAM) to Overweight

Jan 16, 2024 07:27 AM Beam Therapeutics Inc (BEAM) PT Lowered to $66 at Stifel

Jan 8, 2024 06:34 AM Beam Therapeutics (BEAM) Highlights Progress Across Base Editing Portfolio

Dec 21, 2023 06:26 AM Beam Therapeutics Inc (BEAM) PT Lowered to $78 at Guggenheim

Dec 15, 2023 07:39 AM BofA Securities Downgrades Beam Therapeutics Inc (BEAM) to Neutral

Dec 14, 2023 06:30 AM Beam Therapeutics Inc. (BEAM) Appoints Christi Shaw to its Board

Dec 8, 2023 02:38 AM Jefferies Downgrades Beam Therapeutics Inc (BEAM) to Hold

Nov 9, 2023 03:29 AM Beam Therapeutics Inc (BEAM) PT Lowered to $26 at Barclays

Nov 8, 2023 06:50 AM Beam, Inc. (BEAM) Tops Q3 EPS by 11c

Oct 31, 2023 06:00 AM Beam Therapeutics (BEAM) to Sell Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease to Eli Lilly for Up to $600M

Oct 25, 2023 06:30 AM Beam Therapeutics (BEAM) Presents Preclinical Data Highlighting Utility and Durability of BEAM-301

Oct 24, 2023 05:04 AM Citi Opens 30-Day Upside Catalyst Watch on Beam Therapeutics Inc. (BEAM)

Oct 20, 2023 03:31 PM Cantor Fitzgerald Downgrades Beam Therapeutics Inc (BEAM) to Neutral

Oct 20, 2023 08:16 AM Beam Therapeutics Inc (BEAM) PT Lowered to $75 at Wells Fargo

Oct 20, 2023 06:06 AM Leerink Partners Downgrades Beam Therapeutics Inc (BEAM) to Market Perform

Oct 19, 2023 01:47 PM Beam Therapeutics Inc (BEAM) PT Lowered to $48 at Wedbush

Oct 19, 2023 08:46 AM Beam Therapeutics (BEAM) Announces Portfolio Prioritization and Strategic Restructuring

Oct 17, 2023 06:33 AM Beam Therapeutics Inc (BEAM) PT Lowered to $32 at Cantor Fitzgerald

Sep 7, 2023 10:01 AM Beam Therapeutics (BEAM) Presents Preclinical Data Highlighting Utility of BEAM-302

Aug 15, 2023 05:08 AM Beam Therapeutics Inc (BEAM) PT Lowered to $35 at Bernstein

Aug 9, 2023 05:51 AM Beam Therapeutics Inc (BEAM) PT Raised to $47 at Credit Suisse

Aug 9, 2023 03:19 AM Beam Therapeutics Inc (BEAM) PT Lowered to $35 at Barclays

Aug 8, 2023 07:53 AM Beam, Inc. (BEAM) Tops Q2 EPS by 34c, beats revenue

May 15, 2023 10:04 AM Beam Therapeutics Inc (BEAM) PT Lowered to $55 at BofA Securities

May 15, 2023 10:04 AM Beam Therapeutics Inc (BEAM) PT Lowered to $55 at BofA Securities

May 11, 2023 06:39 AM Beam Therapeutics Inc (BEAM) PT Lowered to $42 at RBC Capital

May 11, 2023 05:05 AM Beam Therapeutics Inc (BEAM) PT Lowered to $41 at Barclays

May 10, 2023 01:22 PM Beam Therapeutics Inc (BEAM) PT Lowered to $60 at Citi

May 10, 2023 08:50 AM Beam, Inc. (BEAM) Tops Q1 EPS by 1c

Mar 21, 2023 06:30 AM Beam Therapeutics Inc. (BEAM) Appoints Gopi Shanker as Chief Scientific Officer

Mar 21, 2023 03:09 AM Bernstein Starts Beam Therapeutics Inc (BEAM) at Market Perform

Mar 10, 2023 01:12 PM Stifel Lays Out Biotech Names Exposure to SVB Financial Group (SIVB)

Mar 1, 2023 09:18 AM Beam Therapeutics Inc (BEAM) PT Lowered to $75 at JPMorgan

Mar 1, 2023 06:50 AM Beam Therapeutics Inc (BEAM) PT Lowered to $105 at Wells Fargo

Feb 28, 2023 03:05 PM Beam Therapeutics Inc (BEAM) PT Lowered to $47 at Credit Suisse

Feb 1, 2023 05:45 PM Today's most important initiations

Feb 1, 2023 03:18 AM Cantor Fitzgerald Starts Beam Therapeutics Inc (BEAM) at Overweight

Jan 9, 2023 06:35 AM Beam Therapeutics (BEAM) Reports Progress Across Base Editing Portfolio, Outlines 2023 Milestones

Dec 20, 2022 06:38 AM BMO Capital Upgrades Beam Therapeutics Inc (BEAM) to Outperform as Risk/Reward 'Skewed to Upside'

Dec 13, 2022 05:08 AM Citi Starts Beam Therapeutics Inc (BEAM) at Buy

Dec 2, 2022 06:54 AM Beam Therapeutics Inc. (BEAM) said FDA lifts clinical hold on BEAM-201 IND

Nov 7, 2022 04:39 PM Beam Therapeutics Inc (BEAM) PT Lowered to $53 at Credit Suisse

Nov 7, 2022 12:25 PM Beam Therapeutics Inc (BEAM) PT Lowered to $79 at Wedbush